Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 315 entries
Sorted by: Best Match Show Resources per page
The metabolic syndrome: A high-risk state for cancer?.

The American journal of pathology

Cowey S, Hardy RW.
PMID: 17071576
Am J Pathol. 2006 Nov;169(5):1505-22. doi: 10.2353/ajpath.2006.051090.

The metabolic syndrome is composed of cardiovascular risk factors including increased body mass index/waist circumference, blood pressure, plasma glucose, and triglycerides, as well as decreased high-density lipoprotein cholesterol. The essence of the metabolic syndrome lies in the clustering of...

Cite
Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer?. Am J Pathol. 2006;169(5):1505-22doi: 10.2353/ajpath.2006.051090.
Cowey, S., & Hardy, R. W. (2006). The metabolic syndrome: A high-risk state for cancer?. The American journal of pathology, 169(5), 1505-22. https://doi.org/10.2353/ajpath.2006.051090
Cowey, Stephanie, and Hardy, Robert W. "The metabolic syndrome: A high-risk state for cancer?." The American journal of pathology vol. 169,5 (2006): 1505-22. doi: https://doi.org/10.2353/ajpath.2006.051090
Cowey S, Hardy RW. The metabolic syndrome: A high-risk state for cancer?. Am J Pathol. 2006 Nov;169(5):1505-22. doi: 10.2353/ajpath.2006.051090. PMID: 17071576; PMCID: PMC1780220.
Copy Download .nbib Format: NLM
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.

Alzheimer's & dementia : the journal of the Alzheimer's Association

Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ.
PMID: 18631960
Alzheimers Dement. 2008 May;4(3):156-63. doi: 10.1016/j.jalz.2008.03.005.

No abstract available.

Cite
Khachaturian ZS, Petersen RC, Gauthier S, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement. 2008;4(3):156-63doi: 10.1016/j.jalz.2008.03.005.
Khachaturian, Z. S., Petersen, R. C., Gauthier, S., Buckholtz, N., Corey-Bloom, J. P., Evans, B., Fillit, H., Foster, N., Greenberg, B., Grundman, M., Sano, M., Simpkins, J., Schneider, L. S., Weiner, M. W., Galasko, D., Hyman, B., Kuller, L., Schenk, D., Snyder, S., Thomas, R. G., Tuszynski, M. H., Vellas, B., Wurtman, R. J., Snyder, P. J., Frank, R. A., Albert, M., Doody, R., Ferris, S., Kaye, J., Koo, E., Morrison-Bogorad, M., Reisberg, B., Salmon, D. P., Gilman, S., Mohs, R., Aisen, P. S., Breitner, J. C., Cummings, J. L., Kawas, C., Phelps, C., Poirier, J., Sabbagh, M., Touchon, J., Khachaturian, A. S., & Bain, L. J. (2008). A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & dementia : the journal of the Alzheimer's Association, 4(3), 156-63. https://doi.org/10.1016/j.jalz.2008.03.005
Khachaturian, Zaven S, et al. "A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium." Alzheimer's & dementia : the journal of the Alzheimer's Association vol. 4,3 (2008): 156-63. doi: https://doi.org/10.1016/j.jalz.2008.03.005
Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement. 2008 May;4(3):156-63. doi: 10.1016/j.jalz.2008.03.005. PMID: 18631960; PMCID: PMC2544623.
Copy Download .nbib Format: NLM
Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: a systematic review and meta-analysis.

Diabetes care

Harkness E, Macdonald W, Valderas J, Coventry P, Gask L, Bower P.
PMID: 20351228
Diabetes Care. 2010 Apr;33(4):926-30. doi: 10.2337/dc09-1519.

OBJECTIVE: Patients with diabetes suffer high rates of mental health problems, and this combination is associated with poor outcomes. Although effective treatments exist for both diabetes and mental health problems, delivering services for physical and mental health problems separately...

Cite
Harkness E, Macdonald W, Valderas J, et al. Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(4):926-30doi: 10.2337/dc09-1519.
Harkness, E., Macdonald, W., Valderas, J., Coventry, P., Gask, L., & Bower, P. (2010). Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: a systematic review and meta-analysis. Diabetes care, 33(4), 926-30. https://doi.org/10.2337/dc09-1519
Harkness, Elaine, et al. "Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: a systematic review and meta-analysis." Diabetes care vol. 33,4 (2010): 926-30. doi: https://doi.org/10.2337/dc09-1519
Harkness E, Macdonald W, Valderas J, Coventry P, Gask L, Bower P. Identifying psychosocial interventions that improve both physical and mental health in patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2010 Apr;33(4):926-30. doi: 10.2337/dc09-1519. PMID: 20351228; PMCID: PMC2845054.
Copy Download .nbib Format: NLM
What work has to be done to implement collaborative care for depression? Process evaluation of a trial utilizing the Normalization Process Model.

Implementation science : IS

Gask L, Bower P, Lovell K, Escott D, Archer J, Gilbody S, Lankshear AJ, Simpson AE, Richards DA.
PMID: 20181163
Implement Sci. 2010 Feb 10;5:15. doi: 10.1186/1748-5908-5-15.

BACKGROUND: There is a considerable evidence base for 'collaborative care' as a method to improve quality of care for depression, but an acknowledged gap between efficacy and implementation. This study utilises the Normalisation Process Model (NPM) to inform the...

Cite
Gask L, Bower P, Lovell K, et al. What work has to be done to implement collaborative care for depression? Process evaluation of a trial utilizing the Normalization Process Model. Implement Sci. 2010;5:15doi: 10.1186/1748-5908-5-15.
Gask, L., Bower, P., Lovell, K., Escott, D., Archer, J., Gilbody, S., Lankshear, A. J., Simpson, A. E., & Richards, D. A. (2010). What work has to be done to implement collaborative care for depression? Process evaluation of a trial utilizing the Normalization Process Model. Implementation science : IS, 515. https://doi.org/10.1186/1748-5908-5-15
Gask, Linda, et al. "What work has to be done to implement collaborative care for depression? Process evaluation of a trial utilizing the Normalization Process Model." Implementation science : IS vol. 5 (2010): 15. doi: https://doi.org/10.1186/1748-5908-5-15
Gask L, Bower P, Lovell K, Escott D, Archer J, Gilbody S, Lankshear AJ, Simpson AE, Richards DA. What work has to be done to implement collaborative care for depression? Process evaluation of a trial utilizing the Normalization Process Model. Implement Sci. 2010 Feb 10;5:15. doi: 10.1186/1748-5908-5-15. PMID: 20181163; PMCID: PMC2829490.
Copy Download .nbib Format: NLM
Atomic force microscopy-coupled microcoils for cellular-scale nuclear magnetic resonance spectroscopy.

Applied physics letters

Mousoulis C, Maleki T, Ziaie B, Neu CP.
PMID: 24719493
Appl Phys Lett. 2013 Apr 08;102(14):143702. doi: 10.1063/1.4801318. Epub 2013 Apr 11.

We present the coupling of atomic force microscopy (AFM) and nuclear magnetic resonance (NMR) technologies to enable topographical, mechanical, and chemical profiling of biological samples. Here, we fabricate and perform proof-of-concept testing of radiofrequency planar microcoils on commercial AFM...

Cite
Mousoulis C, Maleki T, Ziaie B, et al. Atomic force microscopy-coupled microcoils for cellular-scale nuclear magnetic resonance spectroscopy. Appl Phys Lett. 2013;102(14):143702doi: 10.1063/1.4801318.
Mousoulis, C., Maleki, T., Ziaie, B., & Neu, C. P. (2013). Atomic force microscopy-coupled microcoils for cellular-scale nuclear magnetic resonance spectroscopy. Applied physics letters, 102(14), 143702. https://doi.org/10.1063/1.4801318
Mousoulis, Charilaos, et al. "Atomic force microscopy-coupled microcoils for cellular-scale nuclear magnetic resonance spectroscopy." Applied physics letters vol. 102,14 (2013): 143702. doi: https://doi.org/10.1063/1.4801318
Mousoulis C, Maleki T, Ziaie B, Neu CP. Atomic force microscopy-coupled microcoils for cellular-scale nuclear magnetic resonance spectroscopy. Appl Phys Lett. 2013 Apr 08;102(14):143702. doi: 10.1063/1.4801318. Epub 2013 Apr 11. PMID: 24719493; PMCID: PMC3637277.
Copy Download .nbib Format: NLM
The European General Practice Research Network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature.

Journal of the American Medical Directors Association

Le Reste JY, Nabbe P, Manceau B, Lygidakis C, Doerr C, Lingner H, Czachowski S, Munoz M, Argyriadou S, Claveria A, Le Floch B, Barais M, Bower P, Van Marwijk H, Van Royen P, Lietard C.
PMID: 23411065
J Am Med Dir Assoc. 2013 May;14(5):319-25. doi: 10.1016/j.jamda.2013.01.001. Epub 2013 Feb 12.

BACKGROUND: Multimorbidity is a new concept encompassing all the medical conditions of an individual patient. The concept links into the European definition of family medicine and its core competencies. However, the definition of multimorbidity and its subsequent operationalization are...

Cite
Le Reste JY, Nabbe P, Manceau B, et al. The European General Practice Research Network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature. J Am Med Dir Assoc. 2013;14(5):319-25doi: 10.1016/j.jamda.2013.01.001.
Le Reste, J. Y., Nabbe, P., Manceau, B., Lygidakis, C., Doerr, C., Lingner, H., Czachowski, S., Munoz, M., Argyriadou, S., Claveria, A., Le Floch, B., Barais, M., Bower, P., Van Marwijk, H., Van Royen, P., & Lietard, C. (2013). The European General Practice Research Network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature. Journal of the American Medical Directors Association, 14(5), 319-25. https://doi.org/10.1016/j.jamda.2013.01.001
Le Reste, Jean Yves, et al. "The European General Practice Research Network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature." Journal of the American Medical Directors Association vol. 14,5 (2013): 319-25. doi: https://doi.org/10.1016/j.jamda.2013.01.001
Le Reste JY, Nabbe P, Manceau B, Lygidakis C, Doerr C, Lingner H, Czachowski S, Munoz M, Argyriadou S, Claveria A, Le Floch B, Barais M, Bower P, Van Marwijk H, Van Royen P, Lietard C. The European General Practice Research Network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature. J Am Med Dir Assoc. 2013 May;14(5):319-25. doi: 10.1016/j.jamda.2013.01.001. Epub 2013 Feb 12. PMID: 23411065.
Copy Download .nbib Format: NLM
Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?.

World journal of cardiology

Zhang L, Mmagu O, Liu L, Li D, Fan Y, Baranchuk A, Kowey PR.
PMID: 25228955
World J Cardiol. 2014 Aug 26;6(8):764-70. doi: 10.4330/wjc.v6.i8.764.

Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in the young, particularly among athletes. Identifying high risk individuals is very important for SCD prevention. The purpose of this review is to stress that noninvasive...

Cite
Zhang L, Mmagu O, Liu L, et al. Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?. World J Cardiol. 2014;6(8):764-70doi: 10.4330/wjc.v6.i8.764.
Zhang, L., Mmagu, O., Liu, L., Li, D., Fan, Y., Baranchuk, A., & Kowey, P. R. (2014). Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?. World journal of cardiology, 6(8), 764-70. https://doi.org/10.4330/wjc.v6.i8.764
Zhang, Li, et al. "Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?." World journal of cardiology vol. 6,8 (2014): 764-70. doi: https://doi.org/10.4330/wjc.v6.i8.764
Zhang L, Mmagu O, Liu L, Li D, Fan Y, Baranchuk A, Kowey PR. Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?. World J Cardiol. 2014 Aug 26;6(8):764-70. doi: 10.4330/wjc.v6.i8.764. PMID: 25228955; PMCID: PMC4163705.
Copy Download .nbib Format: NLM
Reductive activation of neptunyl and plutonyl oxo species with a hydroxypyridinone chelating ligand.

Chemical communications (Cambridge, England)

Carter KP, Jian J, Pyrch MM, Forbes TZ, Eaton TM, Abergel RJ, de Jong WA, Gibson JK.
PMID: 30187044
Chem Commun (Camb). 2018 Sep 20;54(76):10698-10701. doi: 10.1039/c8cc05626a.

Oxo group activation with reduction of neptunyl(vi) and plutonyl(vi) to tetravalent hydroxo species by the hydroxypyridinone siderophore derivative 3,4,3-LI-(1,2-HOPO) was investigated in the gas-phase via electrospray ionization mass spectrometry, in solution via Raman spectroscopy, and computationally via density functional...

Cite
Carter KP, Jian J, Pyrch MM, et al. Reductive activation of neptunyl and plutonyl oxo species with a hydroxypyridinone chelating ligand. Chem Commun (Camb). 2018;54(76):10698-10701doi: 10.1039/c8cc05626a.
Carter, K. P., Jian, J., Pyrch, M. M., Forbes, T. Z., Eaton, T. M., Abergel, R. J., de Jong, W. A., & Gibson, J. K. (2018). Reductive activation of neptunyl and plutonyl oxo species with a hydroxypyridinone chelating ligand. Chemical communications (Cambridge, England), 54(76), 10698-10701. https://doi.org/10.1039/c8cc05626a
Carter, Korey P, et al. "Reductive activation of neptunyl and plutonyl oxo species with a hydroxypyridinone chelating ligand." Chemical communications (Cambridge, England) vol. 54,76 (2018): 10698-10701. doi: https://doi.org/10.1039/c8cc05626a
Carter KP, Jian J, Pyrch MM, Forbes TZ, Eaton TM, Abergel RJ, de Jong WA, Gibson JK. Reductive activation of neptunyl and plutonyl oxo species with a hydroxypyridinone chelating ligand. Chem Commun (Camb). 2018 Sep 20;54(76):10698-10701. doi: 10.1039/c8cc05626a. PMID: 30187044.
Copy Download .nbib Format: NLM
Grapevine Trunk Diseases in British Columbia: Incidence and Characterization of the Fungal Pathogens Associated with Esca and Petri Diseases of Grapevine.

Plant disease

Úrbez-Torres JR, Haag P, Bowen P, O'Gorman DT.
PMID: 30708729
Plant Dis. 2014 Apr;98(4):469-482. doi: 10.1094/PDIS-05-13-0523-RE.

Esca and Petri disease are two economically important grapevine diseases worldwide. This study reports for the first time the occurrence of both diseases on grapevines in British Columbia (BC) and subsequently in Canada. Visual assessment of 55,699 vines in...

Cite
Úrbez-Torres JR, Haag P, Bowen P, et al. Grapevine Trunk Diseases in British Columbia: Incidence and Characterization of the Fungal Pathogens Associated with Esca and Petri Diseases of Grapevine. Plant Dis. 2014;98(4):469-482doi: 10.1094/PDIS-05-13-0523-RE.
Úrbez-Torres, J. R., Haag, P., Bowen, P., & O'Gorman, D. T. (2014). Grapevine Trunk Diseases in British Columbia: Incidence and Characterization of the Fungal Pathogens Associated with Esca and Petri Diseases of Grapevine. Plant disease, 98(4), 469-482. https://doi.org/10.1094/PDIS-05-13-0523-RE
Úrbez-Torres, J R, et al. "Grapevine Trunk Diseases in British Columbia: Incidence and Characterization of the Fungal Pathogens Associated with Esca and Petri Diseases of Grapevine." Plant disease vol. 98,4 (2014): 469-482. doi: https://doi.org/10.1094/PDIS-05-13-0523-RE
Úrbez-Torres JR, Haag P, Bowen P, O'Gorman DT. Grapevine Trunk Diseases in British Columbia: Incidence and Characterization of the Fungal Pathogens Associated with Esca and Petri Diseases of Grapevine. Plant Dis. 2014 Apr;98(4):469-482. doi: 10.1094/PDIS-05-13-0523-RE. PMID: 30708729.
Copy Download .nbib Format: NLM
A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers.

Frontiers in psychiatry

Walsh AEL, Huneke NTM, Brown R, Browning M, Cowen P, Harmer CJ.
PMID: 30386259
Front Psychiatry. 2018 Oct 16;9:482. doi: 10.3389/fpsyt.2018.00482. eCollection 2018.

No abstract available.

Cite
Walsh AEL, Huneke NTM, Brown R, et al. A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers. Front Psychiatry. 2018;9:482doi: 10.3389/fpsyt.2018.00482.
Walsh, A. E. L., Huneke, N. T. M., Brown, R., Browning, M., Cowen, P., & Harmer, C. J. (2018). A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers. Frontiers in psychiatry, 9482. https://doi.org/10.3389/fpsyt.2018.00482
Walsh, Annabel E L, et al. "A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers." Frontiers in psychiatry vol. 9 (2018): 482. doi: https://doi.org/10.3389/fpsyt.2018.00482
Walsh AEL, Huneke NTM, Brown R, Browning M, Cowen P, Harmer CJ. A Dissociation of the Acute Effects of Bupropion on Positive Emotional Processing and Reward Processing in Healthy Volunteers. Front Psychiatry. 2018 Oct 16;9:482. doi: 10.3389/fpsyt.2018.00482. eCollection 2018. PMID: 30386259; PMCID: PMC6198095.
Copy Download .nbib Format: NLM
[No title available]

ACS biomaterials science & engineering

Ghosh S, Cimino JG, Scott AK, Damen FW, Phillips EH, Veress AI, Neu CP, Goergen CJ.
PMID: 29276759
ACS Biomater Sci Eng. 2017 Nov 13;3(11):2798-2805. doi: 10.1021/acsbiomaterials.6b00772. Epub 2017 Feb 17.

Biological tissues have a complex hierarchical architecture that spans organ to subcellular scales and comprises interconnected biophysical and biochemical machinery. Mechanotransduction, gene regulation, gene protection, and structure-function relationships in tissues depend on how force and strain are modulated from...

Cite
Ghosh S, Cimino JG, Scott AK, et al. . ACS Biomater Sci Eng. 2017;3(11):2798-2805doi: 10.1021/acsbiomaterials.6b00772.
Ghosh, S., Cimino, J. G., Scott, A. K., Damen, F. W., Phillips, E. H., Veress, A. I., Neu, C. P., & Goergen, C. J. (2017). . ACS biomaterials science & engineering, 3(11), 2798-2805. https://doi.org/10.1021/acsbiomaterials.6b00772
Ghosh, Soham, et al. "." ACS biomaterials science & engineering vol. 3,11 (2017): 2798-2805. doi: https://doi.org/10.1021/acsbiomaterials.6b00772
Ghosh S, Cimino JG, Scott AK, Damen FW, Phillips EH, Veress AI, Neu CP, Goergen CJ. . ACS Biomater Sci Eng. 2017 Nov 13;3(11):2798-2805. doi: 10.1021/acsbiomaterials.6b00772. Epub 2017 Feb 17. PMID: 29276759; PMCID: PMC5737751.
Copy Download .nbib Format: NLM
Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study.

Journal of atrial fibrillation

Conti S, Reiffel JA, Gersh BJ, Kowey PR, Wachter R, Halperin JL, Kaplon RE, Pouliot E, Verma A.
PMID: 29250279
J Atr Fibrillation. 2017 Feb 28;9(5):1551. doi: 10.4022/jafib.1551. eCollection 2017.

Given the high prevalence and risk of stroke associated with atrial fibrillation (AF), detection strategies have important public health implications. The ongoing prospective, single-arm, open-label, multicenter REVEAL AF trial is evaluating the incidence of previously undetected AF using an...

Cite
Conti S, Reiffel JA, Gersh BJ, et al. Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study. J Atr Fibrillation. 2017;9(5):1551doi: 10.4022/jafib.1551.
Conti, S., Reiffel, J. A., Gersh, B. J., Kowey, P. R., Wachter, R., Halperin, J. L., Kaplon, R. E., Pouliot, E., & Verma, A. (2017). Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study. Journal of atrial fibrillation, 9(5), 1551. https://doi.org/10.4022/jafib.1551
Conti, Sergio, et al. "Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study." Journal of atrial fibrillation vol. 9,5 (2017): 1551. doi: https://doi.org/10.4022/jafib.1551
Conti S, Reiffel JA, Gersh BJ, Kowey PR, Wachter R, Halperin JL, Kaplon RE, Pouliot E, Verma A. Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study. J Atr Fibrillation. 2017 Feb 28;9(5):1551. doi: 10.4022/jafib.1551. eCollection 2017. PMID: 29250279; PMCID: PMC5673395.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 315 entries